C57BL/6JCya-Fscn2em1/Cya
Common Name
Fscn2-KO
Product ID
S-KO-16891
Backgroud
C57BL/6JCya
Strain ID
KOCMP-238021-Fscn2-B6J-VB
When using this mouse strain in a publication, please cite “Fscn2-KO Mouse (Catalog S-KO-16891) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Fscn2-KO
Strain ID
KOCMP-238021-Fscn2-B6J-VB
Gene Name
Product ID
S-KO-16891
Gene Alias
A930022G03, Ahl8, C630046B20Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 11
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000026445
NCBI RefSeq
NM_172802
Target Region
Exon 2
Size of Effective Region
~0.6 kb
Overview of Gene Research
Fscn2, also known as Fascin2, encodes an actin cross-linking protein. It is involved in the formation of hair cell stereocilia and retina structure, and may play a role in cell migration and invasion as part of the FSCN family [2,5]. Mutations in Fscn2 have been linked to hearing impairment and retinal degeneration in humans and mice, suggesting its importance in maintaining ear and eye function [2,4]. Genetic mouse models are valuable for studying Fscn2 function.
In Fscn2 knockout mice, there is progressive loss of hearing and hair cells, along with upregulation of PARVB, which leads to inhibition of the ILK-AKT pathway and cochlear cell death [2]. These mice also show progressive photoreceptor degeneration, structural abnormalities of the outer segment, and depressed rod and cone electroretinograms, indicating that haploinsufficiency of Fscn2 may result in photoreceptor degeneration, similar to human autosomal dominant retinitis pigmentosa [1]. Additionally, Fscn2-/-mice are more susceptible to cisplatin-induced hearing impairment and cochlear cell apoptosis [3].
In conclusion, Fscn2 is essential for maintaining ear and eye function. Gene knockout mouse models have revealed its role in preventing cochlear cell death and photoreceptor degeneration, providing insights into the mechanisms of genetic hearing loss and retinal diseases. High expression of Fscn2 may also be a favorable biomarker for predicting clinical outcomes in multiple myeloma [2,3,4,5].
References:
1. Yokokura, Shunji, Wada, Yuko, Nakai, Shigeyasu, Tamai, Makoto, Noda, Tetsuo. . Targeted disruption of FSCN2 gene induces retinopathy in mice. In Investigative ophthalmology & visual science, 46, 2905-15. doi:. https://pubmed.ncbi.nlm.nih.gov/16043865/
2. Liu, Rongrong, Shang, Wenjing, Liu, Yingying, Song, Xicheng, Han, Fengchan. 2024. Inhibition of the ILK-AKT pathway by upregulation of PARVB contributes to the cochlear cell death in Fascin2 gene knockout mice. In Cell death discovery, 10, 89. doi:10.1038/s41420-024-01851-5. https://pubmed.ncbi.nlm.nih.gov/38374196/
3. Wang, Yan, Liu, Yingying, Xie, Yi, Shang, Wenjing, Han, Fengchan. 2024. Loss of Fascin2 increases susceptibility to cisplatin-induced hearing impairment and cochlear cell apoptosis in mice. In Journal of otology, 19, 133-139. doi:10.1016/j.joto.2024.07.001. https://pubmed.ncbi.nlm.nih.gov/39735238/
4. Liu, Xiang, Zhao, Mengmeng, Xie, Yi, Jin, Changzhu, Han, Fengchan. 2018. Null Mutation of the Fascin2 Gene by TALEN Leading to Progressive Hearing Loss and Retinal Degeneration in C57BL/6J Mice. In G3 (Bethesda, Md.), 8, 3221-3230. doi:10.1534/g3.118.200405. https://pubmed.ncbi.nlm.nih.gov/30082328/
5. Deng, Cong, Si, Chaozeng, Ye, Xu, Zheng, Yongjiang, Qian, Tingting. 2021. Prognostic significance of FSCN family in multiple myeloma. In Journal of Cancer, 12, 1936-1944. doi:10.7150/jca.53675. https://pubmed.ncbi.nlm.nih.gov/33753991/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
